Dalansay, Anabel M.

HRN: 07-75-89  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2026
CEFUROXIME 500MG (TAB)
05/22/2026
05/28/2026
ORAL
500mg
BID
SP PLTCS
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines